GlaxoSmithKline (($GSK)) announced an update on their ongoing clinical study. Study Overview: GlaxoSmithKline (GSK) is conducting a Phase 3 ...

An announcement from GlaxoSmithKline ( ($GB:GSK) ) is now available. GSK has announced the purchase of 248,000 of its own ordinary shares as part ...

Results of a recent study show adults with cardiovascular disease (CVD) have an increased risk of contracting shingles.

Amid a report that the COVID-19 antibody treatment from Regeneron loses its effectiveness against the omicron variant, GlaxoSmithKline and Vir Biotechnology said on Tuesday that their antibody drug is ...

The pharmaceutical and biotechnology company GlaxoSmithKline has fired one of their employees who launched into a homophobic and racist rant whilst on an American Airlines flight. In viral video ...

GlaxoSmithKline withheld studies that made their drug Avandia, look unsafe. July 14, 2010— -- In the face of mounting evidence that GlaxoSmithKline withheld important safety data on their ...

Last January, when GlaxoSmithKline’s ViiV Healthcare won a long-awaited approval for its long-acting HIV treatment Cabenuva, it was hailed as a game-changer as it removed the burden of taking a daily ...

Unlike peers, GSK plc faces limited Loss of Exclusivity risk, supporting steady revenue projections and justifying higher valuation multiples. Learn more about GSK stock here.

Shares of GlaxoSmithKline rose on Monday, while Unilever stock tumbled following a failed $68 billion bid by the latter to acquire the pharmaceutical giant’s consumer healthcare arm. Barbara Kollmeyer ...

The positions in the table below reflect the GlaxoSmithKline USA's position overall, domestically, within their sector, and in various subject areas based on their Share. Each position links to the ...

Forbes contributors publish independent expert analyses and insights. #1 stock picker for 39 straight months on SumZero. Data is my edge. This week’s Filing Season Finds report highlights some of the ...